The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1013
ISSUE1013
November 7, 1997
Two New Retinoids for Psoriasis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Two New Retinoids for Psoriasis
November 7, 1997 (Issue: 1013)
The US Food and Drug Administration (FDA) has approved two new retinoids for treatment of psoriasis. Tazarotene gel 0.05% and 0.1% (Tazorac - Allergan) is being marketed for topical use in patients with stable, mild to moderate plaque psoriasis....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.